| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 9 | 2021 | 302 | 2.390 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 10 | 2021 | 28 | 2.080 |
Why?
|
| Lactic Acid | 9 | 2021 | 112 | 1.550 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 968 | 1.490 |
Why?
|
| High-Throughput Screening Assays | 6 | 2021 | 74 | 1.450 |
Why?
|
| Glycolysis | 9 | 2021 | 71 | 1.340 |
Why?
|
| Biological Products | 3 | 2016 | 91 | 1.300 |
Why?
|
| Cell Survival | 24 | 2021 | 945 | 1.260 |
Why?
|
| Cell Line, Tumor | 25 | 2025 | 2676 | 1.110 |
Why?
|
| Glioma | 7 | 2016 | 96 | 1.090 |
Why?
|
| Hydroxamic Acids | 2 | 2018 | 33 | 1.080 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 46 | 1.050 |
Why?
|
| Neuroblastoma | 11 | 2012 | 136 | 1.040 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2021 | 64 | 0.950 |
Why?
|
| Cytostatic Agents | 2 | 2021 | 6 | 0.890 |
Why?
|
| Monoamine Oxidase | 5 | 2012 | 37 | 0.820 |
Why?
|
| Mitochondria | 8 | 2012 | 523 | 0.810 |
Why?
|
| Plants, Medicinal | 4 | 2013 | 57 | 0.800 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2021 | 134 | 0.780 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2017 | 187 | 0.770 |
Why?
|
| Glucose | 7 | 2020 | 244 | 0.770 |
Why?
|
| Environment | 2 | 2014 | 149 | 0.720 |
Why?
|
| Dioscorea | 1 | 2021 | 4 | 0.720 |
Why?
|
| Thiophenes | 1 | 2021 | 32 | 0.710 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 704 | 0.690 |
Why?
|
| Pyridones | 1 | 2021 | 50 | 0.690 |
Why?
|
| Herbicides | 2 | 2012 | 43 | 0.670 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2020 | 4 | 0.660 |
Why?
|
| Nitric Oxide Synthase | 5 | 2005 | 135 | 0.660 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 291 | 0.640 |
Why?
|
| Hydrogen Peroxide | 7 | 2012 | 190 | 0.630 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 1723 | 0.610 |
Why?
|
| Gene Expression | 2 | 2021 | 701 | 0.580 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 24 | 0.570 |
Why?
|
| Imidazoles | 2 | 2018 | 142 | 0.560 |
Why?
|
| Microglia | 3 | 2016 | 208 | 0.550 |
Why?
|
| Boswellia | 1 | 2017 | 2 | 0.550 |
Why?
|
| Naphthoquinones | 1 | 2018 | 41 | 0.550 |
Why?
|
| Triterpenes | 1 | 2017 | 18 | 0.540 |
Why?
|
| Neurons | 4 | 2018 | 1263 | 0.530 |
Why?
|
| Cytokines | 3 | 2020 | 678 | 0.530 |
Why?
|
| Melanoma | 1 | 2018 | 110 | 0.520 |
Why?
|
| Animals | 37 | 2019 | 16992 | 0.520 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 12 | 0.510 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 17 | 0.510 |
Why?
|
| Antioxidants | 6 | 2015 | 443 | 0.500 |
Why?
|
| Seeds | 1 | 2017 | 46 | 0.500 |
Why?
|
| Vitis | 1 | 2017 | 37 | 0.490 |
Why?
|
| Momordica | 2 | 2019 | 14 | 0.490 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 29 | 0.490 |
Why?
|
| Rats | 22 | 2019 | 3735 | 0.480 |
Why?
|
| Signal Transduction | 6 | 2018 | 2157 | 0.480 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2017 | 1124 | 0.470 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.470 |
Why?
|
| Humans | 33 | 2025 | 43102 | 0.450 |
Why?
|
| Dopamine | 6 | 2004 | 275 | 0.440 |
Why?
|
| Neoplasms | 2 | 2020 | 1377 | 0.440 |
Why?
|
| Neurogenesis | 1 | 2015 | 63 | 0.440 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 384 | 0.430 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 36 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 10 | 2014 | 508 | 0.420 |
Why?
|
| Escherichia coli | 1 | 2016 | 460 | 0.410 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 2012 | 28 | 0.410 |
Why?
|
| Lipopolysaccharides | 8 | 2016 | 239 | 0.410 |
Why?
|
| Models, Biological | 3 | 2014 | 712 | 0.410 |
Why?
|
| Pyruvic Acid | 2 | 2003 | 22 | 0.400 |
Why?
|
| Macrophages | 2 | 2016 | 529 | 0.390 |
Why?
|
| Cadmium Compounds | 1 | 2013 | 7 | 0.390 |
Why?
|
| Selenium Compounds | 1 | 2013 | 11 | 0.390 |
Why?
|
| Neuroglia | 2 | 2005 | 133 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 432 | 0.380 |
Why?
|
| Organic Chemicals | 1 | 2013 | 36 | 0.380 |
Why?
|
| Nanocomposites | 1 | 2013 | 22 | 0.380 |
Why?
|
| Ecosystem | 1 | 2014 | 175 | 0.380 |
Why?
|
| Mitosis | 1 | 2013 | 114 | 0.380 |
Why?
|
| Reactive Oxygen Species | 6 | 2018 | 532 | 0.370 |
Why?
|
| Oxidative Phosphorylation | 2 | 2010 | 60 | 0.370 |
Why?
|
| Genome | 1 | 2012 | 149 | 0.350 |
Why?
|
| Mice | 13 | 2016 | 6644 | 0.350 |
Why?
|
| Astrocytes | 3 | 2015 | 244 | 0.340 |
Why?
|
| Antineoplastic Agents | 5 | 2025 | 1019 | 0.340 |
Why?
|
| MicroRNAs | 1 | 2017 | 518 | 0.330 |
Why?
|
| Parkinson Disease | 2 | 2011 | 210 | 0.330 |
Why?
|
| Homeostasis | 1 | 2012 | 192 | 0.330 |
Why?
|
| Chemokine CCL2 | 3 | 2017 | 95 | 0.320 |
Why?
|
| Acids | 1 | 2009 | 19 | 0.310 |
Why?
|
| Disulfides | 3 | 2015 | 95 | 0.300 |
Why?
|
| Cocaine | 6 | 2018 | 251 | 0.300 |
Why?
|
| Benzoquinones | 2 | 2021 | 47 | 0.290 |
Why?
|
| Apigenin | 2 | 2019 | 14 | 0.290 |
Why?
|
| Adenosine Triphosphate | 4 | 2017 | 206 | 0.280 |
Why?
|
| Oxidopamine | 2 | 2005 | 23 | 0.270 |
Why?
|
| Histone Deacetylases | 2 | 2018 | 61 | 0.260 |
Why?
|
| Oxidative Stress | 3 | 2013 | 1003 | 0.260 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.260 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2025 | 157 | 0.260 |
Why?
|
| Nanoparticles | 1 | 2013 | 460 | 0.260 |
Why?
|
| PC12 Cells | 5 | 2019 | 93 | 0.250 |
Why?
|
| Nitric Oxide | 5 | 2018 | 386 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2015 | 128 | 0.240 |
Why?
|
| Cytoprotection | 2 | 2003 | 36 | 0.240 |
Why?
|
| Oxygen Consumption | 4 | 2012 | 110 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2020 | 310 | 0.240 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 269 | 0.240 |
Why?
|
| Isoenzymes | 3 | 2021 | 168 | 0.230 |
Why?
|
| Carboxylic Acids | 1 | 2025 | 15 | 0.230 |
Why?
|
| Cell Cycle | 3 | 2021 | 346 | 0.230 |
Why?
|
| Acetylcysteine | 3 | 2015 | 57 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 196 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 127 | 0.220 |
Why?
|
| Pyrroles | 1 | 2025 | 72 | 0.220 |
Why?
|
| Smoke | 1 | 2005 | 42 | 0.220 |
Why?
|
| Oxidation-Reduction | 6 | 2012 | 457 | 0.220 |
Why?
|
| Prenatal Care | 1 | 2025 | 93 | 0.220 |
Why?
|
| Neurotoxins | 1 | 2005 | 57 | 0.220 |
Why?
|
| Allyl Compounds | 2 | 2015 | 55 | 0.210 |
Why?
|
| Ubiquinone | 1 | 2004 | 23 | 0.210 |
Why?
|
| Interferon-gamma | 4 | 2016 | 269 | 0.210 |
Why?
|
| Acetylcarnitine | 1 | 2003 | 7 | 0.200 |
Why?
|
| Protective Agents | 1 | 2003 | 26 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2012 | 465 | 0.200 |
Why?
|
| Hydroxydopamines | 1 | 2003 | 4 | 0.200 |
Why?
|
| NAD | 1 | 2003 | 45 | 0.200 |
Why?
|
| Gluconeogenesis | 1 | 2003 | 15 | 0.190 |
Why?
|
| Blotting, Western | 5 | 2012 | 883 | 0.190 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 69 | 0.180 |
Why?
|
| Chlorides | 2 | 2013 | 59 | 0.180 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 140 | 0.180 |
Why?
|
| Gallic Acid | 2 | 2012 | 11 | 0.180 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 102 | 0.180 |
Why?
|
| Breast Feeding | 1 | 2023 | 126 | 0.180 |
Why?
|
| Excitatory Amino Acids | 1 | 2001 | 7 | 0.170 |
Why?
|
| Phytotherapy | 1 | 2021 | 75 | 0.170 |
Why?
|
| Isoquinolines | 1 | 2021 | 55 | 0.170 |
Why?
|
| Glutathione | 4 | 2018 | 171 | 0.170 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 92 | 0.170 |
Why?
|
| Paclitaxel | 1 | 2021 | 64 | 0.170 |
Why?
|
| Tetrahydroisoquinolines | 2 | 2021 | 22 | 0.170 |
Why?
|
| Benzamides | 1 | 2021 | 81 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 149 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 53 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2001 | 131 | 0.160 |
Why?
|
| Cyclotides | 1 | 2019 | 4 | 0.160 |
Why?
|
| Interleukin-1alpha | 2 | 2017 | 18 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 388 | 0.150 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 34 | 0.150 |
Why?
|
| Drug Interactions | 3 | 2012 | 150 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.150 |
Why?
|
| Nitrites | 4 | 2015 | 55 | 0.140 |
Why?
|
| Fish Oils | 1 | 1998 | 13 | 0.140 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 307 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2015 | 1271 | 0.140 |
Why?
|
| Neurites | 1 | 2018 | 40 | 0.140 |
Why?
|
| Smoking | 1 | 2005 | 1024 | 0.140 |
Why?
|
| Apoptosis | 4 | 2014 | 1568 | 0.130 |
Why?
|
| Food | 1 | 1998 | 103 | 0.130 |
Why?
|
| Aerobiosis | 2 | 2009 | 15 | 0.130 |
Why?
|
| Anaerobiosis | 2 | 2009 | 18 | 0.130 |
Why?
|
| DNA Repair | 1 | 2018 | 198 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 51 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2016 | 27 | 0.120 |
Why?
|
| Ibuprofen | 1 | 2016 | 34 | 0.120 |
Why?
|
| Molecular Conformation | 1 | 2017 | 155 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2017 | 154 | 0.120 |
Why?
|
| DNA Damage | 1 | 2018 | 356 | 0.120 |
Why?
|
| Neutrophils | 1 | 2016 | 145 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2017 | 462 | 0.120 |
Why?
|
| Hela Cells | 1 | 2017 | 376 | 0.120 |
Why?
|
| Microtubules | 1 | 2016 | 121 | 0.120 |
Why?
|
| Manganese Compounds | 2 | 2013 | 15 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 11 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1070 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 146 | 0.110 |
Why?
|
| Silymarin | 1 | 2015 | 3 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2015 | 27 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 59 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 98 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.110 |
Why?
|
| Histones | 2 | 2015 | 197 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1455 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1621 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2014 | 91 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2017 | 876 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2025 | 570 | 0.100 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2013 | 12 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2014 | 139 | 0.100 |
Why?
|
| Manganese Poisoning | 1 | 2013 | 17 | 0.100 |
Why?
|
| Sulfhydryl Compounds | 1 | 2013 | 51 | 0.100 |
Why?
|
| Florida | 2 | 2025 | 478 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 1092 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 16 | 0.090 |
Why?
|
| Heterochromatin | 1 | 2012 | 19 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 1998 | 192 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2012 | 30 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.090 |
Why?
|
| Time Factors | 3 | 2012 | 1857 | 0.090 |
Why?
|
| Particle Size | 1 | 2013 | 272 | 0.090 |
Why?
|
| Pregnancy Outcome | 2 | 2025 | 102 | 0.090 |
Why?
|
| Ligands | 1 | 2013 | 388 | 0.090 |
Why?
|
| Liliaceae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Boraginaceae | 1 | 2010 | 2 | 0.090 |
Why?
|
| Apiaceae | 1 | 2010 | 3 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.080 |
Why?
|
| Melanins | 1 | 2011 | 42 | 0.080 |
Why?
|
| Kinetics | 2 | 2003 | 695 | 0.080 |
Why?
|
| Vitamins | 1 | 2011 | 81 | 0.080 |
Why?
|
| Prostate | 1 | 2011 | 155 | 0.080 |
Why?
|
| Nucleus Accumbens | 4 | 2000 | 100 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 60 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 241 | 0.080 |
Why?
|
| Corpus Striatum | 4 | 2000 | 121 | 0.080 |
Why?
|
| Alcohols | 1 | 2009 | 14 | 0.080 |
Why?
|
| Fermentation | 1 | 2009 | 39 | 0.080 |
Why?
|
| Ketones | 1 | 2009 | 18 | 0.080 |
Why?
|
| Aldehydes | 1 | 2009 | 70 | 0.080 |
Why?
|
| Amino Acids | 1 | 2009 | 148 | 0.070 |
Why?
|
| Piroxicam | 1 | 2008 | 2 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2008 | 12 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 28 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2012 | 403 | 0.070 |
Why?
|
| Cell Line | 3 | 2015 | 1410 | 0.070 |
Why?
|
| Oxidants | 2 | 2005 | 42 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 458 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 1998 | 352 | 0.060 |
Why?
|
| Superoxides | 2 | 2004 | 57 | 0.060 |
Why?
|
| Child | 2 | 2025 | 3443 | 0.060 |
Why?
|
| Pregnancy | 4 | 2025 | 1772 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 90 | 0.060 |
Why?
|
| Sympatholytics | 1 | 2005 | 13 | 0.060 |
Why?
|
| Garlic | 2 | 2015 | 31 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2004 | 35 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2004 | 13 | 0.050 |
Why?
|
| Motor Activity | 3 | 2008 | 437 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 104 | 0.050 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2003 | 15 | 0.050 |
Why?
|
| Phosphoenolpyruvate | 1 | 2003 | 4 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2025 | 506 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 458 | 0.050 |
Why?
|
| Propidium | 1 | 2003 | 20 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 36 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 36 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 13 | 0.050 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 14 | 0.050 |
Why?
|
| Imines | 1 | 2002 | 9 | 0.050 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Levodopa | 1 | 2002 | 26 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2003 | 169 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 54 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 222 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 108 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 278 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 575 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2000 | 1766 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 43 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 2001 | 59 | 0.040 |
Why?
|
| Mothers | 1 | 2023 | 215 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 135 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 108 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2000 | 141 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 972 | 0.040 |
Why?
|
| Biomimetics | 1 | 2019 | 15 | 0.040 |
Why?
|
| Triazoles | 1 | 2000 | 102 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 592 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1175 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 48 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Clorgyline | 1 | 1998 | 4 | 0.040 |
Why?
|
| Selegiline | 1 | 1998 | 6 | 0.040 |
Why?
|
| Sharks | 1 | 1998 | 3 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 52 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 416 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 64 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 1998 | 48 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1998 | 41 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 188 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2000 | 373 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 100 | 0.030 |
Why?
|
| Inflammation | 1 | 2003 | 758 | 0.030 |
Why?
|
| Petroselinum | 1 | 2017 | 4 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 408 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 224 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1998 | 172 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 96 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 107 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1082 | 0.030 |
Why?
|
| Breast | 1 | 2017 | 139 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 386 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 455 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 15 | 0.030 |
Why?
|
| Butadienes | 1 | 2015 | 29 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 32 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 95 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 21 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 456 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 81 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.030 |
Why?
|
| Selenium | 1 | 1997 | 155 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 119 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 77 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 119 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 114 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 27 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 139 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 195 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 5080 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 28 | 0.030 |
Why?
|
| Cognition | 1 | 1998 | 473 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6081 | 0.030 |
Why?
|
| Male | 7 | 2012 | 23409 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 165 | 0.020 |
Why?
|
| Thymine | 1 | 2013 | 25 | 0.020 |
Why?
|
| Comet Assay | 1 | 2013 | 77 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 138 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 83 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 403 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2012 | 48 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 986 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 52 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2011 | 28 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 148 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 12222 | 0.020 |
Why?
|
| Brain | 1 | 1998 | 1472 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 1177 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.020 |
Why?
|
| Corticosterone | 2 | 1999 | 90 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 218 | 0.020 |
Why?
|
| Catechols | 1 | 2002 | 7 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1869 | 0.010 |
Why?
|
| Free Radicals | 1 | 2002 | 70 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2002 | 46 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2002 | 158 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 518 | 0.010 |
Why?
|
| Tritium | 1 | 2000 | 46 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 23 | 0.010 |
Why?
|
| Amphetamine | 1 | 2000 | 21 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 153 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2000 | 83 | 0.010 |
Why?
|
| Naloxone | 1 | 1999 | 56 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 27 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 109 | 0.010 |
Why?
|
| Morphine | 1 | 1999 | 69 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1998 | 59 | 0.010 |
Why?
|
| Maze Learning | 1 | 1998 | 113 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 211 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 83 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1997 | 10 | 0.010 |
Why?
|
| Microdialysis | 1 | 1997 | 18 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1997 | 27 | 0.010 |
Why?
|
| Quinpirole | 1 | 1997 | 18 | 0.010 |
Why?
|
| Memory | 1 | 1998 | 174 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 258 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1998 | 321 | 0.010 |
Why?
|